bpc-157 safety adverse effects human humans case report Gray Market Peptides: So Much Hype, So Little Data Preclinical safety evaluation of body

Semaglutide works through GLP-1 receptors alone, and Couture Med Spa describes it as "widely recognized for appetite regulation and sustained progress over time," though the practice notes individual results vary and some patients see changes sooner than others

Lancet 402 , 613626 (2023)

Thats one reason, but there are many others as well

This decision reverses a previous ruling that placed approximately 19 peptides on the more restrictive Category 2 list, effectively banning their use in compounded medications due to potential significant safety risks. The reversal came after significant debate and legal challenges from medical providers and pharmacy groups, who argued that the FDA had not presented sufficient evidence to justify the ban